2.88
price down icon2.04%   -0.06
after-market Handel nachbörslich: 2.88
loading

X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten

pulisher
Jul 25, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView

Jul 25, 2026
pulisher
Jul 22, 2026

XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail

Jul 22, 2026
pulisher
Jul 21, 2026

XTLB Stock Price, Quote & Chart - ChartMill

Jul 21, 2026
pulisher
Jul 12, 2026

Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Jul 12, 2026
pulisher
Jun 30, 2026

XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks

Jun 30, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Wondering what's happening in today's after-hours session? - ChartMill

Jun 29, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks

Jun 29, 2026
pulisher
May 29, 2026

XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat

May 29, 2026
pulisher
May 26, 2026

XTLB - Finviz

May 26, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks

May 22, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com

May 22, 2026
pulisher
May 20, 2026

Eastern International Ltd. expands board, appoints two new directors - Investing.com

May 20, 2026
pulisher
May 16, 2026

XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail

May 16, 2026
pulisher
May 07, 2026

XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks

May 07, 2026
pulisher
Apr 30, 2026

XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks

Apr 30, 2026
pulisher
Apr 29, 2026

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks

Apr 29, 2026
pulisher
Apr 28, 2026

Double BottomStock ScreenerCharts - Finviz

Apr 28, 2026
pulisher
Apr 02, 2026

Top GainersStock ScreenerSnapshot - Finviz

Apr 02, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown

Apr 01, 2026
pulisher
Apr 01, 2026

Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Operating cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross profit of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Operating margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total common shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on equity % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Debt to equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Income Statement – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Earnings and Revenue – MUN:HHB0 - TradingView

Mar 26, 2026
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
Kapitalisierung:     |  Volumen (24h):